1. Home
  2. MXCT vs FFA Comparison

MXCT vs FFA Comparison

Compare MXCT & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • FFA
  • Stock Information
  • Founded
  • MXCT 1999
  • FFA 2004
  • Country
  • MXCT United States
  • FFA United States
  • Employees
  • MXCT N/A
  • FFA N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FFA Investment Managers
  • Sector
  • MXCT Health Care
  • FFA Finance
  • Exchange
  • MXCT Nasdaq
  • FFA Nasdaq
  • Market Cap
  • MXCT 375.0M
  • FFA 416.6M
  • IPO Year
  • MXCT 2021
  • FFA N/A
  • Fundamental
  • Price
  • MXCT $4.11
  • FFA $20.66
  • Analyst Decision
  • MXCT Strong Buy
  • FFA
  • Analyst Count
  • MXCT 2
  • FFA 0
  • Target Price
  • MXCT $9.50
  • FFA N/A
  • AVG Volume (30 Days)
  • MXCT 558.7K
  • FFA 26.1K
  • Earning Date
  • MXCT 11-06-2024
  • FFA 01-01-0001
  • Dividend Yield
  • MXCT N/A
  • FFA 6.72%
  • EPS Growth
  • MXCT N/A
  • FFA N/A
  • EPS
  • MXCT N/A
  • FFA N/A
  • Revenue
  • MXCT $45,599,000.00
  • FFA N/A
  • Revenue This Year
  • MXCT N/A
  • FFA N/A
  • Revenue Next Year
  • MXCT $21.27
  • FFA N/A
  • P/E Ratio
  • MXCT N/A
  • FFA N/A
  • Revenue Growth
  • MXCT 19.85
  • FFA N/A
  • 52 Week Low
  • MXCT $3.17
  • FFA $15.84
  • 52 Week High
  • MXCT $5.55
  • FFA $19.30
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 55.35
  • FFA 48.41
  • Support Level
  • MXCT $3.98
  • FFA $19.91
  • Resistance Level
  • MXCT $4.41
  • FFA $21.14
  • Average True Range (ATR)
  • MXCT 0.27
  • FFA 0.28
  • MACD
  • MXCT -0.00
  • FFA -0.08
  • Stochastic Oscillator
  • MXCT 54.64
  • FFA 56.39

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

Share on Social Networks: